Cytek Biosciences Inc. logo

Cytek Biosciences Inc.

CTKB | NASDAQ
Chart Builder DCF Calculator
$5.62
+$0.34 (+6.44%)
Sep 22, 2026, 12:28 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-66.54M -6.02M -12.15M 2.48M 3.03M 19.41M
Depreciation & Amortization
11.98M 10.49M 9.23M 5.66M 1.24M 603K
Stock-Based Compensation
24.59M 26.85M 22.05M 16.6M 6.59M 611K
Other Working Capital
-366K -4.2M -5.68M -4.39M 11.05M -2.11M
Other Non-Cash Items
-3.47M -10.77M -3.34M 2.96M 2.42M 2.07M
Deferred Income Tax
33.56M -2.89M n/a n/a n/a n/a
Change in Working Capital
-4.79M 7.71M -10.51M -39.93M -8.65M -7.54M
Operating Cash Flow
-4.69M 25.38M 5.28M -12.23M 4.63M 15.16M
Capital Expenditures
-4.08M -3.53M -4.83M -9.87M -4.36M -1.55M
Cash Acquisitions
252K -471K -45.13M n/a -16.63M n/a
Purchase of Investments
-278.16M -274.06M -175.94M -46.04M n/a n/a
Sales Maturities Of Investments
292.21M 195M 132M n/a n/a n/a
Other Investing Acitivies
-107K 84K -179K -120K n/a n/a
Investing Cash Flow
10.12M -82.97M -93.89M -55.91M -20.99M -1.55M
Debt Repayment
837K 3.62M -565K 2.93M -2.77M 2.77M
Common Stock Repurchased
-15.07M -21.61M -44.15M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-669K 2.17M 2.9M -209K 642K 169K
Financial Cash Flow
-13.43M -15.82M -41.81M 5.51M 213.56M 122.61M
Net Cash Flow
-7.89M -68.89M -131.87M -65.12M 198.5M 135.63M
Free Cash Flow
-8.77M 21.85M 454K -22.1M 266K 13.61M
Adj. Free Cash Flow
-33.36M -4.99M -21.59M -38.69M -6.32M 13M
Maintenance CapEx
-3.96M -2.69M -1.83M -6.88M -3.23M -809.08K
Growth CapEx
-123.58K -836.03K -3M -2.98M -1.14M -737.92K
Owner Earnings
-8.65M 22.69M 3.46M -19.12M 1.4M 14.35M

© 2026 bestshares.com. All rights reserved.